Literature DB >> 29535442

Benefit of Treatment With Sebelipase-Alfa in a 63-Year-Old Patient With Advanced Liver and Atherosclerotic Disease Due to Lysosomal Acid Lipase Deficiency (LAL-D).

Elmar Aigner1, Alexandra Feldman1, Daniel Neureiter2, Christian Datz3, Vlad Ratziu4, Bernhard Paulweber1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29535442     DOI: 10.1038/ajg.2017.486

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  4 in total

Review 1.  Sebelipase Alfa: A Review in Lysosomal Acid Lipase Deficiency.

Authors:  James E Frampton
Journal:  Am J Cardiovasc Drugs       Date:  2016-12       Impact factor: 3.571

Review 2.  Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction.

Authors:  Željko Reiner; Ornella Guardamagna; Devaki Nair; Handrean Soran; Kees Hovingh; Stefano Bertolini; Simon Jones; Marijana Ćorić; Sebastiano Calandra; John Hamilton; Terence Eagleton; Emilio Ros
Journal:  Atherosclerosis       Date:  2014-04-15       Impact factor: 5.162

Review 3.  Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease.

Authors:  Donna L Bernstein; Helena Hülkova; Martin G Bialer; Robert J Desnick
Journal:  J Hepatol       Date:  2013-02-26       Impact factor: 25.083

4.  A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency.

Authors:  Barbara K Burton; Manisha Balwani; François Feillet; Ivo Barić; T Andrew Burrow; Carmen Camarena Grande; Mahmut Coker; Alejandra Consuelo-Sánchez; Patrick Deegan; Maja Di Rocco; Gregory M Enns; Richard Erbe; Fatih Ezgu; Can Ficicioglu; Katryn N Furuya; John Kane; Christina Laukaitis; Eugen Mengel; Edward G Neilan; Scott Nightingale; Heidi Peters; Maurizio Scarpa; K Otfried Schwab; Vratislav Smolka; Vassili Valayannopoulos; Marnie Wood; Zachary Goodman; Yijun Yang; Stephen Eckert; Sandra Rojas-Caro; Anthony G Quinn
Journal:  N Engl J Med       Date:  2015-09-10       Impact factor: 91.245

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.